News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France), Daiichi Sankyo Co Ltd. Delay Japan’s First Imported Vaccine
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sept. 30 (Bloomberg) -- Sanofi-Aventis SA and Daiichi Sankyo Co. delayed plans to sell the first imported vaccine in Japan because it's taking longer than expected to make the product meet the country's standards.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Asia
Sanofi (France)
Daiichi Sankyo
MORE ON THIS TOPIC
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
·
2 min read
·
Tristan Manalac
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
November 12, 2025
·
1 min read
·
Heather McKenzie